Biologics

Safeguarding the quality of medication is fundamental to protecting the public’s health, especially as ingredients and products come from all over the world. Biologics — such as recombinant therapeutic proteins, vaccines, blood components, tissues and gene therapies — are growing faster than any other segment of medicine. Just as they do for chemical medicines, manufacturers must ensure the purity and quality of the biologics that make their way to patients. USP quality standards serve as the foundation for a robust safety network that assists manufacturers by increasing predictability and reliability, and preserving the integrity of the global supply chain.

monoclonal antibodies

See what’s new in
Biologics at USP

Check out our new blog, newsletter
and other resources that can help
you stay informed and ensure the
quality of biologics and peptides.

image of peptides

Do you want to be a
presenter? 

USP is requesting abstracts for
oral and poster presentations
for the 5th USP Workshop on
Therapeutic Peptides.

What non-product-specific reference standards 
do you need?